Stay updated on Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial
Sign up to get notified when there's something new on the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page.

Latest updates to the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page shows a new Revision: v3.3.2 where Revision: v3.2.0 was previously listed, with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page’s government funding status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedAdded collaborator/institution details: Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, along with a 'Helpful Links Provided by' section.SummaryDifference0.6%

- Check49 days agoChange DetectedRemoved the sponsor/institution entry (Alvin J. Siteman Cancer Center at Barnes‑Jewish Hospital and Washington University School of Medicine) and the 'Helpful Links Provided by' section from the Study Details page.SummaryDifference0.2%

- Check71 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedUpdated page version to v3.1.0 and removed a specific resource entry for Head and neck squamous cell carcinoma.SummaryDifference0.5%

Stay in the know with updates to Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abemaciclib + Nivolumab in Recurrent Head & Neck Clinical Trial page.